Page last updated: 2024-08-25

acemannan and Cytokine Release Syndrome

acemannan has been researched along with Cytokine Release Syndrome in 1 studies

*Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Cong, F; Du, J; Guo, X; Huang, B; Lao, C; Li, D; Li, J; Li, L; Luo, Y; Tong, X; Xu, W; Ye, H1

Other Studies

1 other study(ies) available for acemannan and Cytokine Release Syndrome

ArticleYear
Aloe polymeric acemannan inhibits the cytokine storm in mouse pneumonia models by modulating macrophage metabolism.
    Carbohydrate polymers, 2022, Dec-01, Volume: 297

    Topics: Aloe; Animals; Cytokine Release Syndrome; Cytokines; Glycogen Synthase Kinase 3 beta; Lipopolysaccharides; Macrophages; Mannans; Mice; Phosphatidylinositol 3-Kinases; Plant Extracts; Polysaccharides; Proto-Oncogene Proteins c-akt

2022